News

Published on 18 Mar 2023 on Insider Monkey via Yahoo Finance

HOOKIPA Pharma Inc. (NASDAQ:HOOK) Q4 2022 Earnings Call Transcript


Article preview image

HOOKIPA Pharma Inc. (NASDAQ:HOOK) Q4 2022 Earnings Call Transcript March 15, 2023

Operator: Good morning and thank you for joining the HOOKIPA Pharma Fourth Quarter and Full Year 2022 Earnings and 2022 Outlook Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. I would now pass the call over to Matthew Beck, Executive Director of Investor Relations. Please go ahead.

Matthew Beck: Thank you. A slide deck accompanying today's call is available through the webcast and in the events section of the HOOKIPA website. Please manually advance the slides as we prompt you through them. Joining me today are Chief Executive Officer, Joern Aldag; Chief Financial Officer, Reinhard Kandera; and Chief Medical Officer, Katia Schlienger. During today's call, we will be making certain forward-looking statements. These statements may include statements regarding, among other things, the efficacy, safety and intended utilization of investigational agents, our clinical and non-clinical plans. Our plan to present or report additional data, the anticipated conduct and the source of future clinical trials, regulatory plans, future research and development and possible intended use of cash and investments.

NASDAQ.HOOK price evolution
NASDAQ.REED price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Humacyte stock surge in question: can it sustain today's gains? | Invezz

Shares of Humacyte Inc (NASDAQ: HUMA) nearly doubled on Friday after receiving full approval for ...

Invezz 20 Dec 2024

Is Jim Cramer's 'Cult Stocks' Call the Beginning of the End, or the End of the...

The Nasdaq Composite is up almost 37% this year on the strength of artificial intelligence. The...

247wallst.com 18 Dec 2024

Trump's tariff threat: will it derail 2025's IPO hopes? | Invezz

The stock market’s buoyant reaction to Donald Trump’s return has largely brushed aside the prospe...

Invezz 18 Dec 2024

IPO Blowout Forecast for 2025 Threatened By Trump Tariffs

(Bloomberg) -- Stock markets have been cheering the return of Donald Trump and shrugging off the...

Bloomberg · via Yahoo Finance 18 Dec 2024

Netflix (NASDAQ:NFLX) Trading 0.4% Higher on Analyst Upgrade

Netflix, Inc. (NASDAQ:NFLX – Get Free Report)’s stock price shot up 0.4% on Monday after Oppenhei...

ETF DAILY NEWS 17 Dec 2024

Netflix (NASDAQ:NFLX) Trading 1.1% Higher on Analyst Upgrade

Netflix, Inc. (NASDAQ:NFLX – Get Free Report)’s share price shot up 1.1% on Thursday after Citigr...

ETF DAILY NEWS 6 Dec 2024

Tuesday's Top Insider Moves: Execs Buy and Sell Big in US Stocks By...

Tuesday's Top Insider Moves: Execs Buy and Sell Big in US Stocks

Investing.com 4 Dec 2024

Q3 Earnings Roundup: Chegg (NYSE:CHGG) And The Rest Of The Consumer Subscription...

Access our full analysis of the earnings results here, it’s free. Match Group (NASDAQ:MTCH)...

StockStory · via Yahoo Finance 29 Nov 2024

With 65% ownership of the shares, Gannett Co., Inc. (NYSE:GCI) is heavily...

Key Insights Given the large stake in the stock by institutions, Gannett's stock price might be...

Simply Wall St. · via Yahoo Finance 28 Nov 2024

The best movie musicals of all time, from Singin' in the Rain to Grease

With...at the onslaught of pop star concert documentaries with a self-referential comedy about a...

Yahoo Movies UK 25 Nov 2024